Glass Russell Monroe 4

What Happened
Russell Glass, a director of Evolent Health (EVH), was granted 41,096 restricted stock units (RSUs) on June 4, 2026. The grant is reported as an award (transaction code A) with an acquisition price of $0 (typical for RSU grants), so the reported cash value at grant is $0.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-08 (filed within the standard two-business-day window).
• Shares/units granted: 41,096 RSUs; reported acquisition price: $0.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 indicates RSUs were granted under the company’s 2015 Omnibus Incentive Plan; F2 states RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting, subject to continued service; F3 notes the shares are held in a trust for the benefit of Glass and his spouse, for which they are co-trustees and share voting/dispositive power.
• Transaction type: Award/Grant (A) — not an open-market buy or sale.

Context
RSU grants are compensation that convert to actual shares only upon vesting (subject to the vesting conditions above). This award does not represent an immediate purchase or sale of EVH stock and is a routine board/executive compensation action rather than a direct market sentiment signal.